<span itemprop="author">Patricia Bencivenga and Adriane Fugh-Berman, MD

Author's posts

Depriving women of this drug is good public health

It’s a public health win that on October 19th, an FDA Advisory Committee voted 14-1 to remove Makena, a drug intended to prevent preterm birth, from the market. The FDA usually follows the advice of its advisory committee, and the briefing docume…